33,270.00
0.01 BRL
2.30 B BRL
15.31 B BRL
About BioMarin Pharmaceutical Inc.
Sector
Industry
CEO
Alexander Hardy
Website
Headquarters
San Rafael
Founded
1997
ISIN
BRB1MRBDR001
FIGI
BBG00RD5Q2Y4
BioMarin Pharmaceutical, Inc. engages in the development and commercialization of therapies for people with serious and life-threatening rare diseases and medical conditions. Its pipeline products include Valoctocogene roxaparvovec, Vosoritide, and BMN 307. The company was founded by John C. Klock, Christopher M. Starr and Grant W. Denison on March 21, 1997, and is headquartered in San Rafael, CA.
BIOMARIN PHARM STOCK PRICE REJECTED AT SUPPORT LEVEL!BMRN declining stock price got rejected at support level at 86, will this cause the stock to rise in coming days?
N.B!
- BMRN price might not follow the drawn lines . Actual price movements may likely differ from the forecast.
- Let emotions and sentiments work for you
- ALWAYS Use Proper Risk Man
Low risk High Reward BMRN?NASDAQ:BMRN finds itself at a point of fight or flight, cornered and being pinned below all-time highs and just above the 0.5 retracement level. A lot can be said about this company: battles with the FDA following the Martin Shkreli controversy, having product approval delayed, and dealing with the
Rectangle Top/Bottom FishingPossibly a bottom formed, time will tell.
3 year high is 131.95 and 3 year low is 62.88. ATH is 151.75 but price gapped down dramatically from this level in the past.
The top appears to have been in a rectangle that broke to the downside. The bottom trendline of the rectangle is now resistance.
See all ideas
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
BMRN5187965
BioMarin Pharmaceutical Inc. 1.25% 15-MAY-2027Yield to maturity
5.51%
Maturity date
May 15, 2027
See all B1MR34 bonds
Curated watchlists where B1MR34 is featured.